Scribe Therapeutics, Inc.

SCTX Nasdaq Healthcare · Biological Products, (No Diagnostic Substances) Alameda, CA www.scribetx.com/
$14.04
Mkt Cap 265.9M

Biotech developing CRISPR-based gene-editing medicines for disease treatment and prevention.

—
/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
Running full 6-factor analysis…